BridgeBio Pharma, Inc. Earnings Per Share (Diluted)
BridgeBio Pharma, Inc. (BBIO) reported Earnings Per Share (Diluted) of -$0.78 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-10
- BridgeBio Pharma, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.78.
- BridgeBio Pharma, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.84.
- BridgeBio Pharma, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.95.
- BridgeBio Pharma, Inc. earnings per share, diluted for the quarter ending 2025-06-30 was -$0.95.
- BridgeBio Pharma, Inc. earnings per share, diluted for fiscal 2025 was -$3.78.
- BridgeBio Pharma, Inc. earnings per share, diluted for fiscal 2024 was -$2.88.
- BridgeBio Pharma, Inc. earnings per share, diluted for fiscal 2023 was -$3.95.
- BridgeBio Pharma, Inc. earnings per share, diluted for fiscal 2022 was -$3.26.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.78 10-Q · filed 2026-08-10 | -$1.62 10-Q · filed 2026-08-10 | ||
| 2026-03-31 | -$0.84 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$3.78 10-K · filed 2026-02-24 | |||
| 2025-09-30 | -$0.95 10-Q · filed 2025-10-29 | -$2.79 10-Q · filed 2025-10-29 | ||
| 2025-06-30 | -$0.95 10-Q · filed 2026-08-10 | -$1.84 10-Q · filed 2026-08-10 | ||
| 2025-03-31 | -$0.88 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | -$2.88 10-K · filed 2026-02-24 | |||
| 2024-09-30 | -$0.86 10-Q · filed 2025-10-29 | -$1.46 10-Q · filed 2025-10-29 | ||
| 2024-06-30 | -$0.39 10-Q · filed 2025-08-05 | -$0.59 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | -$0.20 10-Q · filed 2025-04-29 | |||
| 2023-12-31 | -$3.95 10-K · filed 2026-02-24 | |||
| 2023-09-30 | -$1.08 10-Q · filed 2024-11-12 | -$2.99 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$0.98 10-Q · filed 2024-08-01 | -$1.90 10-Q · filed 2024-08-01 | ||
| 2023-03-31 | -$0.92 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | -$3.26 10-K · filed 2025-02-20 | |||
| 2022-09-30 | -$0.93 10-Q · filed 2023-11-02 | -$2.34 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | -$0.07 10-Q · filed 2023-08-03 | -$1.41 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | -$1.35 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | -$3.90 10-K · filed 2024-02-22 | |||
| 2021-09-30 | -$1.06 10-Q · filed 2022-11-03 | -$2.88 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | -$0.66 10-Q · filed 2022-08-04 | -$1.82 10-Q · filed 2022-08-04 | ||
| 2020-12-31 | -$3.80 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |